A comparison FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment

Haemophilia

Volumn 7, Issue 1, 2001, Pages 39-41

  Cid, A R ^a   Lorenzo, J I ^a   Haya, S ^a   Montoro, J M ^a   Casana P ^a   Aznar, J A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

FVII:C; FVIIa; Haemophilia therapy; Laboratory methods; RFVIIa monitoring

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; ASSAY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MONITORING; HEMOPHILIA A; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL;

ANTIGENS; DRUG MONITORING; FACTOR VII; HEMOPHILIA A; HUMANS; RECOMBINANT PROTEINS;

EID: 0035135796     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2001.00478.x     Document Type: Article

References (9)

1. Successful use of recombinant factor VIIa in a patient with severe hemophilia A during synovectomy
2. Dosing and monitoring NovoSeven® treatment
3. Feasibility of using recombinant factor VIIa in continuous infusion
4. Postoperative use of rFVIIa by continuous infusion in a haemophilic boy
5. Safety, efficacy and lessons from continuous infusion with rFVIIa
6. Determination of activated factor VII (FVIIa) levels in plasma using a clotting assay specific for FVIIa
7. Quantitation of activated factor VII levels in plasma using tissue factor mutant selectively deficient in promoting factor VII activation
8. Factor VII clotting assay: Influence of different thromboplastins and factor VII-deficient plasmas
9. Clinical experience with recombinant factor VIIa